UNITED THERAPEUTICS (UTHR) CFO sells 10,000 shares after exercising options
Rhea-AI Filing Summary
UNITED THERAPEUTICS Corp CFO and Treasurer James Edgemond exercised stock options and sold shares in a planned transaction. He exercised 10,000 stock options for Common Stock at an exercise price of $117.76 per share, then sold 10,000 shares of Common Stock in multiple open-market sales on May 26, 2026.
The sales were executed in numerous trades at weighted average prices within ranges from about $558.79 to $578.53 per share and were carried out under a Rule 10b5-1 trading plan entered into on October 31, 2025. After these transactions, he directly holds 18,876 shares of Common Stock and continues to hold stock options.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 10,000 shares ($4.55M approx. pre-tax spread)
Exercise and Sale
17 txns
Insider
EDGEMOND JAMES
Role
CFO AND TREASURER
Sold
10,000 shs ($5.73M)
Approx. gross sale proceeds
$5.73M
Approx. exercise cost
$1.18M
Approx. pre-tax spread
$4.55M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option | 10,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 10,000 | $117.76 | $1.18M |
| Sale | Common Stock | 25 | $559.5784 | $14K |
| Sale | Common Stock | 135 | $561.2087 | $76K |
| Sale | Common Stock | 280 | $564.0186 | $158K |
| Sale | Common Stock | 240 | $566.3667 | $136K |
| Sale | Common Stock | 520 | $567.3645 | $295K |
| Sale | Common Stock | 1,040 | $568.5377 | $591K |
| Sale | Common Stock | 760 | $569.7903 | $433K |
| Sale | Common Stock | 700 | $570.9212 | $400K |
| Sale | Common Stock | 860 | $571.9323 | $492K |
| Sale | Common Stock | 440 | $572.7024 | $252K |
| Sale | Common Stock | 281 | $574.1309 | $161K |
| Sale | Common Stock | 809 | $575.2417 | $465K |
| Sale | Common Stock | 1,221 | $576.208 | $704K |
| Sale | Common Stock | 1,929 | $577.1302 | $1.11M |
| Sale | Common Stock | 760 | $578.1213 | $439K |
Holdings After Transaction:
Stock Option — 60,000 shares (Direct);
Common Stock — 18,876 shares (Direct)
Footnotes (16)
- F1. This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025.
- F10. This transaction was executed in multiple trades at prices ranging from $571.45 to $572.42. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F11. This transaction was executed in multiple trades at prices ranging from $572.51 to $572.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F12. This transaction was executed in multiple trades at prices ranging from $573.65 to $574.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F13. This transaction was executed in multiple trades at prices ranging from $574.71 to $575.69. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F14. This transaction was executed in multiple trades at prices ranging from $575.71 to $576.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F15. This transaction was executed in multiple trades at prices ranging from $576.73 to $577.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F16. This transaction was executed in multiple trades at prices ranging from $577.84 to $578.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2. This transaction was executed in multiple trades at prices ranging from $558.79 to $559.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3. This transaction was executed in multiple trades at prices ranging from $560.52 to $561.475. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. This transaction was executed in multiple trades at prices ranging from $563.99 to $564.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. This transaction was executed in multiple trades at prices ranging from $565.92 to $566.83. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. This transaction was executed in multiple trades at prices ranging from $566.96 to $567.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7. This transaction was executed in multiple trades at prices ranging from $568.13 to $568.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8. This transaction was executed in multiple trades at prices ranging from $569.41 to $570.295. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9. This transaction was executed in multiple trades at prices ranging from $570.45 to $571.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Key Figures
Shares sold: 10,000 shares
Options exercised: 10,000 stock options
Exercise price: $117.76 per share
+4 more
7 metrics
Shares sold
10,000 shares
Common Stock sold in open-market transactions on May 26, 2026
Options exercised
10,000 stock options
Exercised into Common Stock at $117.76 per share
Exercise price
$117.76 per share
Stock option exercise price for 10,000 shares
Sale price range
$558.79–$578.53 per share
Weighted-average price ranges for multiple sale trades
Post-transaction holdings
18,876 shares
Common Stock directly held after the reported transactions
Remaining stock options
60,000 options
Stock options outstanding after exercise, expiring March 15, 2027
Rule 10b5-1 plan date
October 31, 2025
Date CFO entered into pre-arranged trading plan
Key Terms
Rule 10b5-1 trading plan, weighted average price, stock options, open-market sale, +1 more
5 terms
Rule 10b5-1 trading plan financial
"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into..."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported above reflects the weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
stock options financial
"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan..."
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Common Stock financial
""security_title": "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did UNITED THERAPEUTICS (UTHR) report for CFO James Edgemond?
CFO James Edgemond exercised 10,000 stock options and sold 10,000 shares of UNITED THERAPEUTICS Common Stock in open-market trades on May 26, 2026. These actions were part of a pre-arranged Rule 10b5-1 trading plan disclosed in the filing.
What stock options did the UTHR CFO exercise in this Form 4 filing?
He exercised 10,000 stock options for UNITED THERAPEUTICS Common Stock at an exercise price of $117.76 per share. These options relate to a grant with an expiration date of March 15, 2027, as reflected in the derivative transaction details.
How many stock options remain after the UTHR CFO’s exercise?
After exercising 10,000 options, the Form 4 shows 60,000 stock options remaining for the CFO in that option award. These options have an exercise price of $117.76 and an expiration date of March 15, 2027, according to the derivative holdings table.